P. García Ortega-rekin lankidetzan egindako argitalpenak (8)

2016

  1. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain

    Public Health, Vol. 141, pp. 113-119

2015

  1. Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting

    Pharmacoepidemiology and Drug Safety, Vol. 24, Núm. 1, pp. 93-97

2013

  1. Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 3, pp. 559-564

2012

  1. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): Changes in the consumption pattern following the introduction of extended release methylphenidate

    Pharmacoepidemiology and Drug Safety, Vol. 21, Núm. 4, pp. 435-441

2004

  1. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study

    European Journal of Clinical Pharmacology, Vol. 60, Núm. 6, pp. 439-444

2002

  1. Primary care research needs to be strengthened

    Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria

2001

  1. Cholestatic hepatitis by ticlopidin

    Medicina clínica

  2. Ginecomastia asociada al uso concomitante de cisaprida y lansoprazol

    Medicina Clinica